|
Volumn 45, Issue 4, 2011, Pages 380-381
|
Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: Switching to infliximab is more effective than treating with concomitant immunomodulators
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOSALICYLIC ACID;
AZATHIOPRINE;
CYCLOSPORIN;
INFLIXIMAB;
MERCAPTOPURINE;
METHYLPREDNISOLONE;
COLON RESECTION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
UNSPECIFIED SIDE EFFECT;
6-MERCAPTOPURINE;
ACUTE DISEASE;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
COLECTOMY;
COLITIS, ULCERATIVE;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
HOSPITALIZATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
SALVAGE THERAPY;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
YOUNG ADULT;
|
EID: 79952819227
PISSN: 01920790
EISSN: None
Source Type: Journal
DOI: 10.1097/MCG.0b013e318205e129 Document Type: Letter |
Times cited : (4)
|
References (3)
|